Trial Profile

Multicenter, open-label, randomised trial to assess the efficacy and tolerability of poractant alfa (porcine surfactant, Curosurf) in hospitalized patients with SARS-COV-19 acute respiratory distress syndrome (ARDS)

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 27 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

28 Mar 2022 Status changed from recruiting to discontinued.
02 Feb 2022 Planned End Date changed from 31 Jan 2022 to 15 Apr 2022.
02 Feb 2022 Planned primary completion date changed from 31 Jan 2022 to 15 Apr 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com